Elite Pharmaceuticals Inc (ELTP) stock
ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)
Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –
Elite Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Elite Pharmaceuticals's price to book ratio was 2.6× on Oct 19, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 1.0× to 15.4×, with a median of 3.3×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.6× | −6.0 |
| 2025 | Dec 31, 2025 | 8.5× | −3.7 |
| 2024 | Dec 31, 2024 | 12.2× | +9.1 |
| 2023 | Dec 29, 2023 | 3.1× | +2.0 |
| 2022 | Dec 30, 2022 | 1.1× | −0.4 |
| 2021 | Dec 31, 2021 | 1.5× | −2.0 |
| 2020 | Dec 31, 2020 | 3.5× | −38.1 |
| 2019 | Jan 31, 2019 | 41.5× | +9.2 |
| 2018 | Dec 31, 2018 | 32.3× | +20.9 |
| 2017 | Dec 29, 2017 | 11.4× | +5.5 |
| 2016 | Dec 30, 2016 | 6.0× | – |
See a number that looks wrong?